Taro Pharmaceutical Indus Analyst Ratings
BenzingaJan 18 19:13
HC Wainwright Adjusts Price Target on Taro Pharmaceutical Industries to $35 From $54, Maintains Buy Rating
MT NewswiresJan 25, 2023 22:48
Benzinga Analyst RatingsJan 25, 2023 19:16
No Data